Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.7.0.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2017
Schedule of stock-based compensation expense

 

Included in the accompanying condensed consolidated statements of operations are the following amounts of stock-based compensation for the three months ended March 31, 2017 and 2016 (amounts in thousands):

 

 

 

 

 

 

 

 

 

Three months

 

 

 

ended

 

 

 

March 31,

 

 

 

2017

 

2016

 

Operating expense

    

$

 1

    

 2

 

Selling, general and administrative

 

 

1,220

 

1,546

 

Research and development

 

 

227

 

74

 

 

 

$

1,448

 

1,622

 

 

Series A common stock  
Schedule of stock awards activity

 

 

 

 

 

 

 

 

 

 

 

 

    

    

    

    

 

    

Weighted

    

    

 

 

 

 

 

 

 

 

average

 

 

 

 

 

 

 

 

 

 

remaining

 

Aggregate

 

 

 

 

 

 

 

contractual

 

intrinsic

 

 

Series A

 

WAEP

 

life

 

value

 

 

(in thousands)

 

 

 

 

(in years)

 

(in millions)

Outstanding at January 1, 2017

 

454

 

$

32.47

 

 

 

 

 

Granted

 

 —

 

$

 —

 

 

 

 

 

Exercised

 

(35)

 

$

25.51

 

 

 

 

 

Forfeited/cancelled

 

 —

 

$

 —

 

 

 

 

 

Outstanding at March 31, 2017

 

419

 

$

33.05

 

2.7

 

$

22

Exercisable at March 31, 2017

 

415

 

$

32.95

 

2.7

 

$

22

 

Series C common stock  
Schedule of stock awards activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

    

    

    

 

    

Weighted

    

    

 

 

 

 

 

 

 

 

average

 

 

 

 

 

 

 

 

 

 

remaining

 

Aggregate

 

 

 

 

 

 

 

contractual

 

intrinsic

 

 

Series C

 

WAEP

 

life

 

value

 

 

(in thousands)

 

 

 

 

(in years)

 

(in millions)

Outstanding at January 1, 2017

 

2,467

 

$

42.45

 

 

 

 

 

Granted

 

 —

 

$

 —

 

 

 

 

 

Exercised

 

(69)

 

$

26.24

 

 

 

 

 

Forfeited/cancelled

 

 —

 

$

 —

 

 

 

 

 

Outstanding at March 31, 2017

 

2,398

 

$

42.92

 

5.9

 

$

104

Exercisable at March 31, 2017

 

872

 

$

33.45

 

2.8

 

$

46